These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 2763513)
1. [Effect of immunosuppression on the development and outcome of an acute infection in mice caused by administration of the Lassa virus]. Barkar ND; Mar'iankova RF; Godneva AT; Grigor'eva LV; Zudin BI Vopr Virusol; 1989; 34(2):208-13. PubMed ID: 2763513 [TBL] [Abstract][Full Text] [Related]
2. [Lassa and Mozambique viruses: cross protection in experiments on mice and action of immunosuppressants on experimental infections]. Barkar ND; Lukashevich IS Vopr Virusol; 1989; 34(5):598-603. PubMed ID: 2609647 [TBL] [Abstract][Full Text] [Related]
9. A live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia viruses. Lukashevich IS; Patterson J; Carrion R; Moshkoff D; Ticer A; Zapata J; Brasky K; Geiger R; Hubbard GB; Bryant J; Salvato MS J Virol; 2005 Nov; 79(22):13934-42. PubMed ID: 16254329 [TBL] [Abstract][Full Text] [Related]
10. [An update on Lassa virus]. Leparc-Goffart I; Emonet SF Med Trop (Mars); 2011 Dec; 71(6):541-5. PubMed ID: 22393616 [TBL] [Abstract][Full Text] [Related]
11. [A trial to produce an inactivated Lassa fever vaccine]. Krasnianskiĭ VP; Potryvaeva NV; Borisevich IV; Gradoboev VN; Pashanina TP; Pshenichnov VA Vopr Virusol; 1993; 38(6):276-9. PubMed ID: 8303891 [TBL] [Abstract][Full Text] [Related]
12. [The tragic story of the discovery of the Lassa fever virus]. Muggia A Minerva Med; 1970 Mar; (26 Suppl):16. PubMed ID: 5498893 [No Abstract] [Full Text] [Related]
13. Experimental infection of rhesus monkeys with Lassa virus and a closely related arenavirus, Mozambique virus. Walker DH; Johnson KM; Lange JV; Gardner JJ; Kiley MP; McCormick JB J Infect Dis; 1982 Sep; 146(3):360-8. PubMed ID: 6286795 [TBL] [Abstract][Full Text] [Related]
14. Zidampidine, an aryl phosphate derivative of AZT: in vivo pharmacokinetics, metabolism, toxicity, and anti-viral efficacy against hemorrhagic fever caused by Lassa virus. Uckun FM; Venkatachalam TK; Erbeck D; Chen CL; Petkevich AS; Vassilev A Bioorg Med Chem; 2005 May; 13(9):3279-88. PubMed ID: 15809163 [TBL] [Abstract][Full Text] [Related]
15. Development of a new vaccine for the prevention of Lassa fever. Geisbert TW; Jones S; Fritz EA; Shurtleff AC; Geisbert JB; Liebscher R; Grolla A; Ströher U; Fernando L; Daddario KM; Guttieri MC; Mothé BR; Larsen T; Hensley LE; Jahrling PB; Feldmann H PLoS Med; 2005 Jun; 2(6):e183. PubMed ID: 15971954 [TBL] [Abstract][Full Text] [Related]
16. Broad-spectrum antiviral activity of small interfering RNA targeting the conserved RNA termini of Lassa virus. Müller S; Günther S Antimicrob Agents Chemother; 2007 Jun; 51(6):2215-8. PubMed ID: 17371814 [TBL] [Abstract][Full Text] [Related]